Angiotensin II receptor antagonists

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Phosphorus containing other than solely as part of an...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C548S250000

Reexamination Certificate

active

07947664

ABSTRACT:
A compound having the structurewherein R is an angiotensin receptor antagonist active group,Y is selected from the group consisting ofand2) —C(R1H)OC(O)X((CR12R13)—(CHR10)m—(CH2)n—Zp—(CH2)q—(CHR11)r—(CR16R17))—R5;Z is —O— or —(CR14R15)—;m, n, p, q, and r are independently selected from the group consisting of 0 and 1;X is —O— or —(CR18R19)—;R1is selected from the group consisting of hydrogen, C1-4alkyl, aryl and C1-4alkylaryl;R5is —O—N═N(O)—NR3R4;or a pharmaceutically acceptable salt or hydrate thereof, which is useful for treating hypertension.

REFERENCES:
patent: 5138069 (1992-08-01), Carini et al.
patent: 5366997 (1994-11-01), Keefer et al.
patent: WO2009/099853 (2009-08-01), None
AngiotensinIIReceptorAntagonist, http://en.wikipedia.org/wiki/Angiotensin—II—receptor—antagonist, 2010.
US International Search Report; completed Feb. 24, 2009; Performed by Authorized Officer Lee W. Young.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Angiotensin II receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Angiotensin II receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Angiotensin II receptor antagonists will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2676961

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.